Log In
BCIQ
Print this Print this
 

Azzalure, Dysport, abobotulinumtoxinA (formerly Reloxin)

  Manage Alerts
Collapse Summary General Information
Company Ipsen Group
DescriptionInjectable formulation of botulinum neurotoxin type A complex supplied as a lyophilized powder
Molecular Target
Mechanism of Action 
Therapeutic ModalityBiologic: Protein

 Product Details
Disease CategoryStandard IndicationIndication DetailsPartnersMilestonesLatest Stage of DevelopmentRegulatory Designation
 Archive Items are loading loading
Collapse Summary Deals Information
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments

1

$1,400.0M

$1,400.0M

0


 Deals Details
DateCompanies InvolvedDeal HeadlineTotal Deal ValueTotal Upfront CashTotal Milestone

05/28/2014

$1,400.0M

$1,400.0M

0

Get a free BioCentury trial today